| MP term | FDR (all) | IC level | SDMP level | Annotation (direct or inherited) |
Mammalian Phenotype (MP) | abnormal definitive hematopoiesis | 0.000000001415 | 1.128 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal T cell morphology | 0.000000001753 | 1.362 | -- | DIRECT |
Mammalian Phenotype (MP) | digestive/alimentary phenotype | 0.00000001254 | 0.9281 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal apoptosis | 0.00000004717 | 1.076 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal lymphocyte morphology | 0.0000009579 | 1.061 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal leukopoiesis | 0.0000009882 | 1.229 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal intercellular signaling peptide or protein level | 0.00000137 | 1.429 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal blood cell physiology | 0.000002173 | 0.9281 | -- | DIRECT |
Mammalian Phenotype (MP) | skeleton phenotype | 0.000002797 | 0.8451 | -- | DIRECT |
Mammalian Phenotype (MP) | increased chronic myelocytic leukemia incidence | 0.000002912 | 2.207 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal spinal cord dorsal column morphology | 0.000002912 | 2.207 | -- | DIRECT |
Mammalian Phenotype (MP) | craniofacial phenotype | 0.00001009 | 1.207 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal circulating interferon-gamma level | 0.00001033 | 1.73 | -- | DIRECT |
Mammalian Phenotype (MP) | absent sternum | 0.00001137 | 2.508 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal cell physiology | 0.00001288 | 0.6214 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal cranium morphology | 0.00001422 | 1.304 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal myeloid leukocyte morphology | 0.00002643 | 1.466 | -- | DIRECT |
Mammalian Phenotype (MP) | endocrine/exocrine gland phenotype | 0.00003809 | 0.8003 | -- | DIRECT |
Mammalian Phenotype (MP) | small Peyer's patches | 0.00004636 | 2.207 | -- | DIRECT |
Mammalian Phenotype (MP) | limbs/digits/tail phenotype | 0.00005733 | 1.253 | -- | DIRECT |
Mammalian Phenotype (MP) | no abnormal phenotype detected | 0.00006503 | 1.663 | -- | DIRECT |
Mammalian Phenotype (MP) | embryonic lethality during organogenesis, complete penetrance | 0.00007101 | 2.508 | -- | DIRECT |
Mammalian Phenotype (MP) | muscle phenotype | 0.0001108 | 0.8177 | -- | DIRECT |
Mammalian Phenotype (MP) | acanthosis | 0.0001409 | 2.207 | -- | DIRECT |
Mammalian Phenotype (MP) | epidermis stratum spinosum hyperplasia | 0.0001704 | 2.207 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal dendritic cell number | 0.0001914 | 2.207 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal leukocyte morphology | 0.0002378 | 0.9397 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal hemopoiesis | 0.0002459 | 1.11 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal inguinal lymph node morphology | 0.0002749 | 2.207 | -- | DIRECT |
Mammalian Phenotype (MP) | decreased Peyer's patch number | 0.0003156 | 2.508 | -- | DIRECT |
Mammalian Phenotype (MP) | impaired natural killer cell mediated cytotoxicity | 0.0003572 | 1.73 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal zygomatic arch morphology | 0.0003704 | 2.508 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal hematopoietic system physiology | 0.0003734 | 0.9168 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal lymphopoiesis | 0.0004286 | 1.229 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal dendritic cell morphology | 0.0006294 | 2.207 | -- | DIRECT |
Mammalian Phenotype (MP) | decreased erythroid progenitor cell number | 0.0007459 | 2.508 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal insulin-like growth factor I level | 0.0007552 | 1.809 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal vascular development | 0.0007641 | 1.394 | -- | DIRECT |
Mammalian Phenotype (MP) | homeostasis/metabolism phenotype | 0.00078 | 0.3617 | -- | DIRECT |
Mammalian Phenotype (MP) | increased IgG2a level | 0.0007898 | 2.508 | -- | DIRECT |
Mammalian Phenotype (MP) | embryonic lethality, incomplete penetrance | 0.0008782 | 2.508 | -- | DIRECT |
Mammalian Phenotype (MP) | head tilt | 0.0009429 | 2.207 | -- | DIRECT |
Mammalian Phenotype (MP) | abnormal stomach mucosa morphology | 0.001212 | 2.207 | -- | INHERITED FROM: abnormal stomach epithelium morphology |
Mammalian Phenotype (MP) | abnormal cardiovascular development | 0.00123 | 1.304 | -- | INHERITED FROM: abnormal heart development || abnormal vascular development |
Mammalian Phenotype (MP) | increased hematopoietic cell number | 0.001545 | 1.429 | -- | INHERITED FROM: increased leukocyte cell number |
Mammalian Phenotype (MP) | abnormal skin adnexa morphology | 0.001598 | 1.186 | -- | INHERITED FROM: abnormal mammary gland alveolus morphology || abnormal coat appearance |
Mammalian Phenotype (MP) | abnormal granulocyte morphology | 0.00167 | 1.906 | -- | INHERITED FROM: abnormal granulocyte number |
Mammalian Phenotype (MP) | abnormal response to infection | 0.001708 | 1.253 | -- | INHERITED FROM: increased susceptibility to infection |
Mammalian Phenotype (MP) | abnormal immune system physiology | 0.002552 | 0.737 | -- | INHERITED FROM: increased susceptibility to infection || abnormal level of surface class II molecules || increased IgG2a level || decreased B cell proliferation || abnormal B cell proliferation || respiratory system inflammation || impaired natural killer cell mediated cytotoxicity || abnormal interleukin level || abnormal circulating interferon-gamma level || abnormal leukocyte physiology |
Mammalian Phenotype (MP) | abnormal immune cell physiology | 0.003053 | 0.9638 | -- | INHERITED FROM: abnormal leukocyte physiology || impaired natural killer cell mediated cytotoxicity || abnormal B cell proliferation || decreased B cell proliferation || increased IgG2a level || abnormal level of surface class II molecules |
Mammalian Phenotype (MP) | abnormal cell-mediated immunity | 0.003463 | 0.9638 | -- | INHERITED FROM: abnormal B cell proliferation || impaired natural killer cell mediated cytotoxicity || abnormal leukocyte physiology || abnormal level of surface class II molecules || decreased B cell proliferation || increased IgG2a level |
Mammalian Phenotype (MP) | abnormal immune system morphology | 0.003644 | 0.8003 | -- | INHERITED FROM: decreased dendritic cell number || abnormal mononuclear cell morphology || abnormal thymus morphology || abnormal dendritic cell morphology || abnormal granulocyte number || small Peyer's patches || abnormal T cell morphology || abnormal leukocyte morphology || abnormal thymus medulla morphology || abnormal myeloid leukocyte morphology || abnormal inguinal lymph node morphology || abnormal lymphopoiesis || abnormal T cell differentiation || increased leukocyte cell number || decreased Peyer's patch number || abnormal lymphocyte morphology || abnormal leukopoiesis || abnormal dendritic cell number |
Mammalian Phenotype (MP) | abnormal palate development | 0.003786 | 2.031 | -- | INHERITED FROM: abnormal secondary palate development |
Mammalian Phenotype (MP) | abnormal hepatobiliary system physiology | 0.003952 | 1.304 | -- | INHERITED FROM: abnormal liver physiology |
Mammalian Phenotype (MP) | abnormal adaptive immunity | 0.004461 | 0.9516 | -- | INHERITED FROM: abnormal leukocyte physiology || abnormal B cell proliferation || impaired natural killer cell mediated cytotoxicity || increased IgG2a level || decreased B cell proliferation || abnormal level of surface class II molecules |
Mammalian Phenotype (MP) | behavior/neurological phenotype | 0.004547 | 0.9281 | -- | INHERITED FROM: head tilt |
Mammalian Phenotype (MP) | abnormal apocrine gland morphology | 0.004959 | 1.466 | -- | INHERITED FROM: abnormal mammary gland alveolus morphology |
Mammalian Phenotype (MP) | abnormal gut-associated lymphoid tissue morphology | 0.00586 | 1.73 | -- | INHERITED FROM: small Peyer's patches || decreased Peyer's patch number |
Mammalian Phenotype (MP) | increased malignant tumor incidence | 0.007093 | 1.663 | -- | INHERITED FROM: increased adenocarcinoma incidence |
Mammalian Phenotype (MP) | abnormal endocrine gland morphology | 0.008116 | 1.304 | -- | INHERITED FROM: abnormal thymus medulla morphology || abnormal thymus morphology |
Mammalian Phenotype (MP) | abnormal lymphocyte physiology | 0.01039 | 1.186 | -- | INHERITED FROM: decreased B cell proliferation || increased IgG2a level || abnormal B cell proliferation || impaired natural killer cell mediated cytotoxicity || abnormal level of surface class II molecules |
Mammalian Phenotype (MP) | abnormal antigen presentation | 0.01334 | 1.663 | -- | INHERITED FROM: abnormal level of surface class II molecules |
Mammalian Phenotype (MP) | abnormal respiratory system physiology | 0.01529 | 1.332 | -- | INHERITED FROM: respiratory system inflammation |
Mammalian Phenotype (MP) | abnormal erythroid progenitor cell morphology | 0.02311 | 2.508 | -- | INHERITED FROM: decreased erythroid progenitor cell number |
Mammalian Phenotype (MP) | decreased hematopoietic cell number | 0.02785 | 1.186 | -- | INHERITED FROM: decreased dendritic cell number |
Mammalian Phenotype (MP) | abnormal NK cell physiology | 0.03019 | 1.663 | -- | INHERITED FROM: impaired natural killer cell mediated cytotoxicity |
Mammalian Phenotype (MP) | abnormal cytokine level | 0.03446 | 1.466 | -- | INHERITED FROM: abnormal interleukin level || abnormal circulating interferon-gamma level |
Mammalian Phenotype (MP) | abnormal leukocyte cell number | 0.03942 | 1.045 | -- | INHERITED FROM: abnormal dendritic cell number || increased leukocyte cell number || abnormal granulocyte number || decreased dendritic cell number |
Mammalian Phenotype (MP) | lethality throughout fetal growth and development | 0.04688 | 1.809 | -- | INHERITED FROM: lethality throughout fetal growth and development, complete penetrance |
Mammalian Phenotype (MP) | increased tumor incidence | 0.04772 | 1.11 | -- | INHERITED FROM: increased chronic myelocytic leukemia incidence || increased adenocarcinoma incidence |
Mammalian Phenotype (MP) | abnormal circulating interferon level | 0.04948 | 1.663 | -- | INHERITED FROM: abnormal circulating interferon-gamma level |
Mammalian Phenotype (MP) | abnormal immunoglobulin level | 0.05515 | 1.605 | -- | INHERITED FROM: increased IgG2a level |
Mammalian Phenotype (MP) | abnormal motor capabilities/coordination/movement | 0.06303 | 1.229 | -- | INHERITED FROM: head tilt |
Mammalian Phenotype (MP) | abnormal professional antigen presenting cell morphology | 0.06506 | 1.277 | -- | INHERITED FROM: decreased dendritic cell number || abnormal dendritic cell morphology || abnormal dendritic cell number |
Mammalian Phenotype (MP) | abnormal antigen presentation via MHC class II | 0.06662 | 1.809 | -- | INHERITED FROM: abnormal level of surface class II molecules |
Mammalian Phenotype (MP) | abnormal craniofacial bone morphology | 0.06706 | 1.304 | -- | INHERITED FROM: abnormal cranium morphology || abnormal zygomatic arch morphology |
Mammalian Phenotype (MP) | abnormal innate immunity | 0.08759 | 1.277 | -- | INHERITED FROM: impaired natural killer cell mediated cytotoxicity |
Mammalian Phenotype (MP) | abnormal cervical vertebrae morphology | 0.09247 | 2.031 | -- | INHERITED FROM: abnormal cervical atlas morphology |
Mammalian Phenotype (MP) | abnormal circulating protein level | 0.09786 | 1.253 | -- | INHERITED FROM: abnormal circulating interferon-gamma level |
Mammalian Phenotype (MP) | abnormal B cell physiology | 0.09874 | 1.229 | -- | INHERITED FROM: abnormal level of surface class II molecules || decreased B cell proliferation || increased IgG2a level || abnormal B cell proliferation |
Mammalian Phenotype (MP) | increased immunoglobulin level | 0.1047 | 2.207 | -- | INHERITED FROM: increased IgG2a level |
Mammalian Phenotype (MP) | abnormal stomach wall morphology | 0.106 | 2.207 | -- | INHERITED FROM: abnormal stomach epithelium morphology |
Mammalian Phenotype (MP) | abnormal Peyer's patch number | 0.1105 | 2.508 | -- | INHERITED FROM: decreased Peyer's patch number |
Mammalian Phenotype (MP) | abnormal presacral vertebrae morphology | 0.1186 | 1.663 | -- | INHERITED FROM: abnormal cervical atlas morphology |
Mammalian Phenotype (MP) | abnormal hematopoietic system morphology/development | 0.1187 | 0.7444 | -- | INHERITED FROM: abnormal hemopoiesis || abnormal blood cell morphology || decreased erythroid progenitor cell number || abnormal T cell morphology || decreased dendritic cell number || abnormal mononuclear cell morphology || abnormal dendritic cell morphology || abnormal thymus morphology || abnormal granulocyte number || increased leukocyte cell number || abnormal T cell differentiation || abnormal dendritic cell number || abnormal leukopoiesis || abnormal lymphocyte morphology || abnormal definitive hematopoiesis || abnormal myeloid leukocyte morphology || abnormal leukocyte morphology || abnormal thymus medulla morphology || abnormal lymphopoiesis || abnormal blood cell morphology/development |
Mammalian Phenotype (MP) | abnormal skin adnexa physiology | 0.1448 | 1.809 | -- | INHERITED FROM: abnormal mammary gland epithelium physiology |
Mammalian Phenotype (MP) | abnormal mammary gland physiology | 0.1542 | 1.906 | -- | INHERITED FROM: abnormal mammary gland epithelium physiology |
Mammalian Phenotype (MP) | abnormal exocrine gland morphology | 0.1543 | 1.253 | -- | INHERITED FROM: abnormal mammary gland alveolus morphology |
Mammalian Phenotype (MP) | abnormal B cell activation | 0.1588 | 1.663 | -- | INHERITED FROM: decreased B cell proliferation || abnormal B cell proliferation |
Mammalian Phenotype (MP) | abnormal mammary gland lobule morphology | 0.1616 | 1.906 | -- | INHERITED FROM: abnormal mammary gland alveolus morphology |
Mammalian Phenotype (MP) | increased IgG2 level | 0.177 | 2.508 | -- | INHERITED FROM: increased IgG2a level |
Mammalian Phenotype (MP) | abnormal classified tumor incidence | 0.1856 | 1.207 | -- | INHERITED FROM: increased adenocarcinoma incidence || increased chronic myelocytic leukemia incidence |
Mammalian Phenotype (MP) | abnormal mouth morphology | 0.2423 | 1.73 | -- | INHERITED FROM: abnormal secondary palate development || cleft palate |
Mammalian Phenotype (MP) | abnormal apocrine gland physiology | 0.2487 | 1.906 | -- | INHERITED FROM: abnormal mammary gland epithelium physiology |
Mammalian Phenotype (MP) | abnormal exocrine gland physiology | 0.2645 | 1.906 | -- | INHERITED FROM: abnormal mammary gland epithelium physiology |
Mammalian Phenotype (MP) | abnormal organ/body region tumor incidence | 0.2724 | 1.186 | -- | INHERITED FROM: increased chronic myelocytic leukemia incidence |
Mammalian Phenotype (MP) | abnormal facial morphology | 0.2748 | 1.605 | -- | INHERITED FROM: abnormal secondary palate development || cleft palate |
Mammalian Phenotype (MP) | abnormal palate morphology | 0.2782 | 1.906 | -- | INHERITED FROM: abnormal secondary palate development || cleft palate |
Mammalian Phenotype (MP) | abnormal circulating hormone level | 0.2796 | 1.128 | -- | INHERITED FROM: abnormal circulating insulin-like growth factor I level |
Mammalian Phenotype (MP) | abnormal axial skeleton morphology | 0.2965 | 1.128 | -- | INHERITED FROM: abnormal vertebral arch morphology || absent sternum || abnormal zygomatic arch morphology || abnormal intervertebral disk morphology || abnormal cervical atlas morphology || abnormal cranium morphology |
Mammalian Phenotype (MP) | abnormal skin morphology | 0.2974 | 1.229 | -- | INHERITED FROM: epidermis stratum spinosum hyperplasia || acanthosis |
Mammalian Phenotype (MP) | increased inflammatory response | 0.2994 | 1.146 | -- | INHERITED FROM: respiratory system inflammation |
Mammalian Phenotype (MP) | abnormal immune system cell morphology | 0.3153 | 0.9281 | -- | INHERITED FROM: abnormal leukopoiesis || abnormal dendritic cell number || abnormal T cell morphology || abnormal lymphocyte morphology || increased leukocyte cell number || abnormal T cell differentiation || abnormal granulocyte number || abnormal lymphopoiesis || abnormal dendritic cell morphology || abnormal myeloid leukocyte morphology || decreased dendritic cell number || abnormal mononuclear cell morphology || abnormal leukocyte morphology |
Mammalian Phenotype (MP) | preweaning lethality | 0.3205 | 0.8266 | -- | INHERITED FROM: embryonic lethality during organogenesis, complete penetrance || embryonic lethality, incomplete penetrance || lethality throughout fetal growth and development, complete penetrance |
Mammalian Phenotype (MP) | increased classified tumor incidence | 0.3206 | 1.207 | -- | INHERITED FROM: increased adenocarcinoma incidence || increased chronic myelocytic leukemia incidence |
Mammalian Phenotype (MP) | abnormal blood circulation | 0.3286 | 1.277 | -- | INHERITED FROM: hemorrhage |
Mammalian Phenotype (MP) | abnormal nervous system morphology | 0.3412 | 0.627 | -- | INHERITED FROM: abnormal spinal cord dorsal column morphology |
Mammalian Phenotype (MP) | abnormal stationary movement | 0.3555 | 2.031 | -- | INHERITED FROM: head tilt |
Mammalian Phenotype (MP) | abnormal IgG level | 0.3686 | 1.73 | -- | INHERITED FROM: increased IgG2a level |
Mammalian Phenotype (MP) | abnormal thymus lobule morphology | 0.4124 | 1.906 | -- | INHERITED FROM: abnormal thymus medulla morphology |
Mammalian Phenotype (MP) | increased organ/body region tumor incidence | 0.4289 | 1.186 | -- | INHERITED FROM: increased chronic myelocytic leukemia incidence |
Mammalian Phenotype (MP) | abnormal craniofacial development | 0.4369 | 2.031 | -- | INHERITED FROM: abnormal secondary palate development |
Mammalian Phenotype (MP) | abnormal survival | 0.4648 | 0.7297 | -- | INHERITED FROM: embryonic lethality, incomplete penetrance || lethality throughout fetal growth and development, complete penetrance || embryonic lethality during organogenesis, complete penetrance |
Mammalian Phenotype (MP) | abnormal cardiovascular system morphology | 0.5069 | 0.8266 | -- | INHERITED FROM: abnormal vascular development || abnormal heart development |
Mammalian Phenotype (MP) | altered susceptibility to infection | 0.5326 | 1.253 | -- | INHERITED FROM: increased susceptibility to infection |
Mammalian Phenotype (MP) | altered tumor susceptibility | 0.5518 | 1.11 | -- | INHERITED FROM: increased chronic myelocytic leukemia incidence || increased adenocarcinoma incidence |
Mammalian Phenotype (MP) | abnormal pectoral girdle bone morphology | 0.5878 | 1.73 | -- | INHERITED FROM: absent sternum |
Mammalian Phenotype (MP) | abnormal coat/ hair morphology | 0.6379 | 1.605 | -- | INHERITED FROM: abnormal coat appearance |
Mammalian Phenotype (MP) | abnormal hematopoietic cell morphology | 0.6541 | 0.8177 | -- | INHERITED FROM: abnormal granulocyte number || abnormal dendritic cell morphology || decreased dendritic cell number || abnormal mononuclear cell morphology || abnormal T cell morphology || decreased erythroid progenitor cell number || abnormal blood cell morphology || abnormal hemopoiesis || abnormal lymphopoiesis || abnormal myeloid leukocyte morphology || abnormal definitive hematopoiesis || abnormal leukocyte morphology || abnormal dendritic cell number || abnormal leukopoiesis || abnormal lymphocyte morphology || increased leukocyte cell number || abnormal T cell differentiation |
Mammalian Phenotype (MP) | embryonic lethality | 0.724 | 1.304 | -- | INHERITED FROM: embryonic lethality, incomplete penetrance || embryonic lethality during organogenesis, complete penetrance |
Mammalian Phenotype (MP) | abnormal vertebral column morphology | 0.8011 | 1.362 | -- | INHERITED FROM: abnormal cervical atlas morphology || abnormal vertebral arch morphology || abnormal intervertebral disk morphology |
Mammalian Phenotype (MP) | abnormal IgG2 level | 0.8113 | 1.906 | -- | INHERITED FROM: increased IgG2a level |
Mammalian Phenotype (MP) | abnormal tumor incidence | 0.9317 | 1.11 | -- | INHERITED FROM: increased chronic myelocytic leukemia incidence || increased adenocarcinoma incidence |
Mammalian Phenotype (MP) | abnormal blood homeostasis | 1 | 0.7085 | -- | INHERITED FROM: abnormal circulating interferon-gamma level || abnormal circulating insulin-like growth factor I level |
Mammalian Phenotype (MP) | growth/size/body region phenotype | 0.000001613 | 0.7017 | Least Informative | DIRECT |
Mammalian Phenotype (MP) | mortality/aging | 0.000002072 | 0.5888 | Least Informative | DIRECT |
Mammalian Phenotype (MP) | cellular phenotype | 0.0001991 | 0.5301 | Least Informative | DIRECT |
Mammalian Phenotype (MP) | cardiovascular system phenotype | 0.0003387 | 0.6818 | Least Informative | DIRECT |
Mammalian Phenotype (MP) | hematopoietic system phenotype | 0.006084 | 0.6505 | Least Informative | INHERITED FROM: increased leukocyte cell number || abnormal T cell differentiation || abnormal leukopoiesis || abnormal dendritic cell number || abnormal lymphocyte morphology || abnormal blood cell physiology || abnormal myeloid leukocyte morphology || abnormal definitive hematopoiesis || abnormal thymus medulla morphology || abnormal leukocyte morphology || abnormal B cell proliferation || abnormal blood cell morphology/development || decreased B cell proliferation || increased IgG2a level || abnormal lymphopoiesis || abnormal level of surface class II molecules || abnormal blood cell morphology || abnormal hemopoiesis || impaired natural killer cell mediated cytotoxicity || abnormal T cell morphology || decreased erythroid progenitor cell number || abnormal leukocyte physiology || abnormal thymus morphology || abnormal dendritic cell morphology || abnormal mononuclear cell morphology || decreased dendritic cell number || abnormal granulocyte number || abnormal hematopoietic system physiology |
Mammalian Phenotype (MP) | immune system phenotype | 0.00757 | 0.627 | Least Informative | INHERITED FROM: decreased B cell proliferation || increased IgG2a level || abnormal lymphopoiesis || abnormal level of surface class II molecules || abnormal myeloid leukocyte morphology || abnormal B cell proliferation || respiratory system inflammation || increased susceptibility to infection || decreased dendritic cell number || abnormal leukocyte physiology || abnormal thymus morphology || abnormal circulating interferon-gamma level || small Peyer's patches || impaired natural killer cell mediated cytotoxicity || abnormal inguinal lymph node morphology || abnormal leukocyte morphology || abnormal thymus medulla morphology || abnormal leukopoiesis || abnormal dendritic cell number || decreased Peyer's patch number || abnormal lymphocyte morphology || increased leukocyte cell number || abnormal T cell differentiation || abnormal granulocyte number || abnormal mononuclear cell morphology || abnormal dendritic cell morphology || abnormal T cell morphology || abnormal interleukin level |
Mammalian Phenotype (MP) | nervous system phenotype | 0.027 | 0.5166 | Least Informative | INHERITED FROM: abnormal spinal cord dorsal column morphology |
Mammalian Phenotype (MP) | abnormal homeostasis | 0.1983 | 0.495 | Least Informative | INHERITED FROM: abnormal fluid regulation || abnormal interleukin level || abnormal intercellular signaling peptide or protein level || abnormal circulating interferon-gamma level || abnormal circulating insulin-like growth factor I level || impaired adaptive thermogenesis || abnormal insulin-like growth factor I level |
Mammalian Phenotype (MP) | abnormal blood cell morphology/development | 0.000000009842 | 1.093 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal leukocyte physiology | 0.0000004954 | 0.9764 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal skeleton morphology | 0.0000008399 | 0.8951 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | integument phenotype | 0.00000123 | 0.8451 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | embryo phenotype | 0.000001871 | 0.9058 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | respiratory system phenotype | 0.000005384 | 0.9893 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal gland morphology | 0.000009362 | 0.8644 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal craniofacial morphology | 0.000009631 | 1.207 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal mononuclear cell morphology | 0.00002864 | 0.9764 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal blood cell morphology | 0.00008684 | 1.016 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | liver/biliary system phenotype | 0.0008506 | 0.9397 | Moderately Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal inflammatory response | 0.001434 | 1.076 | Moderately Informative | INHERITED FROM: respiratory system inflammation |
Mammalian Phenotype (MP) | abnormal immune serum protein physiology | 0.003571 | 1.11 | Moderately Informative | INHERITED FROM: abnormal interleukin level || abnormal circulating interferon-gamma level || increased IgG2a level |
Mammalian Phenotype (MP) | abnormal cell death | 0.005867 | 1.045 | Moderately Informative | INHERITED FROM: abnormal apoptosis |
Mammalian Phenotype (MP) | abnormal cardiovascular system physiology | 0.01525 | 0.9168 | Moderately Informative | INHERITED FROM: hemorrhage |
Mammalian Phenotype (MP) | abnormal immune system organ morphology | 0.01999 | 1.186 | Moderately Informative | INHERITED FROM: abnormal thymus morphology || abnormal thymus medulla morphology || small Peyer's patches || abnormal inguinal lymph node morphology || decreased Peyer's patch number |
Mammalian Phenotype (MP) | abnormal hematopoietic cell number | 0.03041 | 0.9764 | Moderately Informative | INHERITED FROM: abnormal granulocyte number || decreased dendritic cell number || abnormal dendritic cell number || increased leukocyte cell number |
Mammalian Phenotype (MP) | neoplasm | 0.03167 | 1.003 | Moderately Informative | INHERITED FROM: increased adenocarcinoma incidence || altered tumor pathology || increased chronic myelocytic leukemia incidence |
Mammalian Phenotype (MP) | abnormal blood vessel morphology | 0.03407 | 1.016 | Moderately Informative | INHERITED FROM: abnormal vascular development |
Mammalian Phenotype (MP) | abnormal myeloid cell morphology | 0.0484 | 1.229 | Moderately Informative | INHERITED FROM: abnormal myeloid leukocyte morphology || abnormal granulocyte number || decreased erythroid progenitor cell number |
Mammalian Phenotype (MP) | abnormal heart morphology | 0.0545 | 1.076 | Moderately Informative | INHERITED FROM: abnormal heart development |
Mammalian Phenotype (MP) | lethality during fetal growth through weaning | 0.0582 | 1.229 | Moderately Informative | INHERITED FROM: lethality throughout fetal growth and development, complete penetrance |
Mammalian Phenotype (MP) | prenatal lethality | 0.08255 | 1.076 | Moderately Informative | INHERITED FROM: embryonic lethality during organogenesis, complete penetrance || embryonic lethality, incomplete penetrance || lethality throughout fetal growth and development, complete penetrance |
Mammalian Phenotype (MP) | abnormal digestive system morphology | 0.1005 | 1.031 | Moderately Informative | INHERITED FROM: abnormal stomach epithelium morphology || abnormal secondary palate development || cleft palate |
Mammalian Phenotype (MP) | abnormal protein level | 0.1339 | 1.146 | Moderately Informative | INHERITED FROM: abnormal circulating interferon-gamma level || abnormal intercellular signaling peptide or protein level || abnormal interleukin level |
Mammalian Phenotype (MP) | abnormal professional antigen presenting cell physiology | 0.4805 | 1.11 | Moderately Informative | INHERITED FROM: increased IgG2a level || decreased B cell proliferation || abnormal B cell proliferation || abnormal level of surface class II molecules |
Mammalian Phenotype (MP) | abnormal hormone level | 0.7243 | 1.076 | Moderately Informative | INHERITED FROM: abnormal insulin-like growth factor I level || abnormal circulating insulin-like growth factor I level |
Mammalian Phenotype (MP) | abnormal behavior | 1 | 0.9397 | Moderately Informative | INHERITED FROM: head tilt |
Mammalian Phenotype (MP) | abnormal interleukin level | 0.00000001067 | 1.605 | Informative | DIRECT |
Mammalian Phenotype (MP) | increased susceptibility to infection | 0.0000003063 | 1.466 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal liver physiology | 0.000003189 | 1.394 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal thymus morphology | 0.00001343 | 1.508 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal coat appearance | 0.00002017 | 1.605 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal T cell differentiation | 0.00002985 | 1.605 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal fluid regulation | 0.00004723 | 1.554 | Informative | DIRECT |
Mammalian Phenotype (MP) | normal phenotype | 0.00006634 | 1.605 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal B cell proliferation | 0.0001193 | 1.663 | Informative | DIRECT |
Mammalian Phenotype (MP) | hemorrhage | 0.0001351 | 1.394 | Informative | DIRECT |
Mammalian Phenotype (MP) | altered tumor pathology | 0.0003112 | 1.554 | Informative | DIRECT |
Mammalian Phenotype (MP) | increased leukocyte cell number | 0.0004405 | 1.554 | Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal cartilage morphology | 0.002027 | 1.605 | Informative | INHERITED FROM: abnormal intervertebral disk morphology |
Mammalian Phenotype (MP) | abnormal humoral immune response | 0.003854 | 1.508 | Informative | INHERITED FROM: increased IgG2a level |
Mammalian Phenotype (MP) | abnormal adaptive thermogenesis | 0.004057 | 1.73 | Informative | INHERITED FROM: impaired adaptive thermogenesis |
Mammalian Phenotype (MP) | abnormal spinal cord morphology | 0.008815 | 1.663 | Informative | INHERITED FROM: abnormal spinal cord dorsal column morphology |
Mammalian Phenotype (MP) | abnormal epidermal layer morphology | 0.01021 | 1.554 | Informative | INHERITED FROM: epidermis stratum spinosum hyperplasia || acanthosis |
Mammalian Phenotype (MP) | abnormal circulating cytokine level | 0.01213 | 1.508 | Informative | INHERITED FROM: abnormal circulating interferon-gamma level |
Mammalian Phenotype (MP) | abnormal gland physiology | 0.02284 | 1.554 | Informative | INHERITED FROM: abnormal mammary gland epithelium physiology |
Mammalian Phenotype (MP) | abnormal B lymphocyte antigen presentation | 0.02882 | 1.663 | Informative | INHERITED FROM: abnormal level of surface class II molecules |
Mammalian Phenotype (MP) | abnormal lymph node morphology | 0.04135 | 1.508 | Informative | INHERITED FROM: abnormal inguinal lymph node morphology |
Mammalian Phenotype (MP) | abnormal head morphology | 0.04153 | 1.429 | Informative | INHERITED FROM: cleft palate || abnormal secondary palate development |
Mammalian Phenotype (MP) | abnormal interferon level | 0.07086 | 1.663 | Informative | INHERITED FROM: abnormal circulating interferon-gamma level |
Mammalian Phenotype (MP) | abnormal mammary gland morphology | 0.07522 | 1.466 | Informative | INHERITED FROM: abnormal mammary gland alveolus morphology |
Mammalian Phenotype (MP) | abnormal appendicular skeleton morphology | 0.07944 | 1.429 | Informative | INHERITED FROM: absent sternum |
Mammalian Phenotype (MP) | abnormal thoracic cage morphology | 0.241 | 1.73 | Informative | INHERITED FROM: absent sternum |
Mammalian Phenotype (MP) | abnormal natural killer cell mediated cytotoxicity | 0.2425 | 1.663 | Informative | INHERITED FROM: impaired natural killer cell mediated cytotoxicity |
Mammalian Phenotype (MP) | abnormal stomach morphology | 0.3273 | 1.73 | Informative | INHERITED FROM: abnormal stomach epithelium morphology |
Mammalian Phenotype (MP) | increased hemolymphoid system tumor incidence | 0.3512 | 1.508 | Informative | INHERITED FROM: increased chronic myelocytic leukemia incidence |
Mammalian Phenotype (MP) | increased carcinoma incidence | 0.3811 | 1.663 | Informative | INHERITED FROM: increased adenocarcinoma incidence |
Mammalian Phenotype (MP) | abnormal voluntary movement | 0.4831 | 1.429 | Informative | INHERITED FROM: head tilt |
Mammalian Phenotype (MP) | abnormal erythroid lineage cell morphology | 0.5382 | 1.605 | Informative | INHERITED FROM: decreased erythroid progenitor cell number |
Mammalian Phenotype (MP) | abnormal vertebrae morphology | 0.6989 | 1.508 | Informative | INHERITED FROM: abnormal vertebral arch morphology || abnormal cervical atlas morphology |
Mammalian Phenotype (MP) | abnormal Peyer's patch morphology | 0.8938 | 1.73 | Informative | INHERITED FROM: small Peyer's patches || decreased Peyer's patch number |
Mammalian Phenotype (MP) | decreased B cell proliferation | 0.000006213 | 2.031 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal mammary gland epithelium physiology | 0.000009099 | 2.031 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | respiratory system inflammation | 0.000009657 | 2.207 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | lethality throughout fetal growth and development, complete penetrance | 0.00002637 | 2.031 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal secondary palate development | 0.00006071 | 2.031 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal intervertebral disk morphology | 0.0001097 | 1.906 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | decreased dendritic cell number | 0.00012 | 2.207 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | impaired adaptive thermogenesis | 0.0001287 | 2.031 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal cervical atlas morphology | 0.0001553 | 2.031 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal stomach epithelium morphology | 0.0001704 | 2.207 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | cleft palate | 0.0002123 | 2.207 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal level of surface class II molecules | 0.0002749 | 1.809 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal thymus medulla morphology | 0.0003089 | 1.906 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal heart development | 0.0003219 | 1.809 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal circulating insulin-like growth factor I level | 0.0005441 | 1.809 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | increased adenocarcinoma incidence | 0.0006211 | 2.031 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal granulocyte number | 0.0006533 | 2.031 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal mammary gland alveolus morphology | 0.0008596 | 1.906 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal vertebral arch morphology | 0.0008597 | 2.031 | Highly Informative | DIRECT |
Mammalian Phenotype (MP) | abnormal spinal cord white matter morphology | 0.008997 | 2.031 | Highly Informative | INHERITED FROM: abnormal spinal cord dorsal column morphology |
Mammalian Phenotype (MP) | abnormal IgG2a level | 0.01023 | 1.906 | Highly Informative | INHERITED FROM: increased IgG2a level |
Mammalian Phenotype (MP) | abnormal head movements | 0.01327 | 2.031 | Highly Informative | INHERITED FROM: head tilt |
Mammalian Phenotype (MP) | increased leukemia incidence | 0.01366 | 2.031 | Highly Informative | INHERITED FROM: increased chronic myelocytic leukemia incidence |
Mammalian Phenotype (MP) | abnormal bone marrow cell morphology/development | 0.01868 | 2.031 | Highly Informative | INHERITED FROM: decreased erythroid progenitor cell number |
Mammalian Phenotype (MP) | embryonic lethality during organogenesis | 0.0599 | 1.906 | Highly Informative | INHERITED FROM: embryonic lethality during organogenesis, complete penetrance |
Mammalian Phenotype (MP) | abnormal Peyer's patch size | 0.1245 | 1.906 | Highly Informative | INHERITED FROM: small Peyer's patches |
Mammalian Phenotype (MP) | abnormal peripheral lymph node morphology | 0.1485 | 2.031 | Highly Informative | INHERITED FROM: abnormal inguinal lymph node morphology |
Mammalian Phenotype (MP) | abnormal epidermis stratum spinosum morphology | 0.2192 | 2.031 | Highly Informative | INHERITED FROM: acanthosis || epidermis stratum spinosum hyperplasia |
Mammalian Phenotype (MP) | abnormal neurocranium morphology | 0.2649 | 1.809 | Highly Informative | INHERITED FROM: abnormal zygomatic arch morphology |
Mammalian Phenotype (MP) | increased IgG level | 0.356 | 2.207 | Highly Informative | INHERITED FROM: increased IgG2a level |
Mammalian Phenotype (MP) | abnormal sternum morphology | 0.8426 | 1.906 | Highly Informative | INHERITED FROM: absent sternum |